Back To Blog

NIH Studies Its Processes to Ensure Diversity in Clinical Trials

The NIH supports over $31 billion of biomedical and public health research and has long been concerned with the underrepresentation of minority groups in clinical trials and its effect of on these populations.

The NIH’s Office of Evaluation and Inspections has recently announced a study to review how the NIH monitors and responds to clinical studies that do not meet their commitments to inclusive enrollment as part of their approved enrollment plans for NIH funded research. Monitoring and ensuring these commitments are met, present challenges and require specific responses which the study will also evaluate.

 
Visit the HHS Office of the Inspector General’s summary page for more information and links to other active work plans as well as their work plan archive.